Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health.
3 contributing indexes 4 score components composite score.
Canonical asset packet first: fundamentals, macro index exposure, entry value, and active narrative alignment. Driver rows link back to the public index that moved the score.
| Index | Driver | Reason | Weight | Condition | Contribution | As Of |
|---|---|---|---|---|---|---|
| RQRI | Risk-Quality Rotation Index | risk appetite | 9% | risk appetite — tailwind Moderate signal—/100Tailwind +1.30σ | +0.085 | 2026-05-22 |
| LFSI | Liquidity & Financial Stress Index | liquidity conditions | 23% | liquidity conditions — tailwind Near normal—/100Tailwind +0.13σ | +0.042 | 2026-05-22 |
| CRSI | Credit Spread Intensity Index | credit spreads | 10% | credit spreads — headwind Near normal—/100Headwind -0.27σ | -0.036 | 2026-05-22 |
